One of the strains of the cold virus can be an effective tool against bladder cancer, Clinical Cancer Research reported.
Scientists from the University of Surrey and Royal Surrey County Hospital investigated the safety and efficacy of using Coxsackievirus (CVA21) against bladder cancer.
Studies have shown that a cold virus strain called the Coxsackievirus (CVA21) has destroyed cancer cells in the inner lining of the bladder. The study involved 15 patients. They all suffered from non-muscular invasive bladder cancer.
During the week of the planned surgery to excise the tumor, they received experimental treatment. In most cases, the virus led to cell death within the tumor just one week after the start of treatment. And one of the patients in the body did not have any traces of the disease.
As it turned out, CVA21 infected cancer cells inside the bladder, causing the organ to become inflamed. Because of the inflammatory processes, immune cells rushed here, which destroyed the tumor cells.
The authors of the study believe that this method of treatment of bladder cancer, which is not accompanied by serious side effects, may become a new word in oncology.